Comparison of Staples Versus Subcuticular Suture in Class III Obese Women Undergoing Cesarean Delivery

NCT ID: NCT02466776

Last Updated: 2024-01-09

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

238 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-06-30

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the optimal skin closure technique (staples versus subcuticular suture) at the time of cesarean delivery in Class III obese women with body mass index (BMI) of \>/= 40kg/m2.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A. To assess the rate of wound complications with staples versus subcuticular suture closure in women with a BMI of ≥ 40 kg/m2 undergoing cesarean delivery (CD).

B. No difference was observed in wound complication rates between staples and subcuticular suture skin closure in women with a BMI ≥ 40 kg/m2 undergoing cesarean delivery (CD).

C. At this time, optimal skin closure method in obese women with BMI ≥ 40 kg/m2 undergoing cesarean delivery remains unknown. More work is needed in this area to help reduce the complication rate in this very high-risk population.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity, Severe Cesarean Section

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stainless steel staples

Patients in this arm will receive stainless steel staples for skin closure at time of cesarean delivery (CD).

Group Type ACTIVE_COMPARATOR

Stainless steel staples

Intervention Type DEVICE

Patients will receive stainless steel staples for skin closure at time of cesarean delivery (CD).

Absorbable subcuticular Suture

Patients will receive absorbable subcuticular suture for skin closure at time of cesarean delivery (CD).

Group Type ACTIVE_COMPARATOR

Absorbable subcuticular suture

Intervention Type DEVICE

Patients will receive absorbable subcuticular suture for skin closure at time of cesarean delivery (CD).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Absorbable subcuticular suture

Patients will receive absorbable subcuticular suture for skin closure at time of cesarean delivery (CD).

Intervention Type DEVICE

Stainless steel staples

Patients will receive stainless steel staples for skin closure at time of cesarean delivery (CD).

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

3-0 monocryl Staples

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Women \> 18 years old undergoing cesarean delivery (CD)
2. BMI of \>/= 40 kg/m2 as determined by height and weight reported during their admission
3. Live gestation 23 weeks or greater
4. Women who are able to follow-up 7-14 days after hospital discharge for a visual wound check.

Exclusion Criteria

1. Active lupus flare
2. HIV/AIDS
3. Current treatment for cancer or h/o radiation to the abdomen/pelvis
4. Hypersensitivity to steri-strips
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of California, Irvine

OTHER

Sponsor Role collaborator

MemorialCare Health System

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jennifer McNulty, MD

Maternal Fetal Medicine Specialist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jennifer McNulty, MD

Role: PRINCIPAL_INVESTIGATOR

MemoriaCare HealthSystem

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Long Beach Memorial Care Center for Women at Miller Children's Hospital Long Beach and Long Beach Memorial Hospital

Long Beach, California, United States

Site Status

Long Beach Memorial Care Center for Women at Miller Children's Hospital Long Beach

Long Beach, California, United States

Site Status

Long Beach Memorial Care Center

Long Beach, California, United States

Site Status

University of California, Irvine

Orange, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

459-14

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.